Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
Background: People with cystic fibrosis, who are chronically colonised with the organism Pseudomonas aeruginosa, often require multiple courses of intravenous aminoglycoside antibiotics for the management of pulmonary exacerbations. The properties of aminoglycosides suggest that they could be given...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014
|
| Online Access: | http://eprints.nottingham.ac.uk/31689/ http://eprints.nottingham.ac.uk/31689/ http://eprints.nottingham.ac.uk/31689/ http://eprints.nottingham.ac.uk/31689/1/Smyth%20Cochrane%202014%20Once%20vs%203%20times%20daily.pdf |